Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis - a Multicenter Randomised Double-blind Clinical Trial

NCT01244958 is registered in ClinicalTrials.gov with Frank Behrens as lead sponsor.

NCT NCT01244958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01244958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis - a Multicenter Randomised Double-blind Clinical Trial
Lead sponsor
Frank Behrens
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2010
Completion date
February 28, 2015
Enrollment
156 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis